Abstract

ROLE OF ARTIFICIAL INTELLIGENCE IN PHARMA SECTOR: A COMPREHENSIVE REVIEW

Dakshayini, Kapil Raghuwanshi, Agilandeswari Devarajan, Ujwal Kumar U., Deepak Saini, Chanchal Sharma, Yash Dhubkaria, Shubham Sanjay Pachorkar and Anil Kumar*

ABSTRACT

The goal of artificial intelligence is to create intelligent modeling, which facilitates knowledge conception, problem solving, and decision making. The initial research that is currently known as artificial intelligence was conducted in 1943 by Warren McCulloch and Walter Pits. Artificial intelligence (AI) was once thought to be exclusive to the engineering domain. However, in the pharmacy industry, AI is now widely used in many different domains, including drug discovery, formulation development for drug delivery, marketing, management, marketing, quality assurance, and hospital pharmacy. Different Artificial Neural Networks, such as Deep Neural Networks or Recurrent Neural Networks, are used in drug discovery and drug delivery formulation development. The potential of the technology in quantitative structure-property relationships or quantitative structure-activity relationships has recently been examined and backed by a number of drug discovery implementations. Furthermore, de novo design encourages the development of substantially noveler pharmacological molecules in terms of desired or ideal characteristics. Nowadays, doctors use robots for a variety of medical operations because they are more reliable than humans, have more advanced job capabilities, and can do any task quickly and efficiently. We conclude that artificial intelligence (AI) is the new, developing field in every industry, including pharmacy, and that it needs further development in order to update the state of the art and conduct new research. This review discusses the role of artificial intelligence in many areas of the pharmaceutical industry.

Keywords: Artificial Intelligence, Pharma, Technology, AutoDock Vina, ORKIN.